AI Therapeutics Company
AI Therapeutics develops drugs for rare diseases and cancer.
Technology:
Artificial Intelligence, Biotechnology, Genetics, Machine Learning, Medical, Therapeutics
Industry:
AI, End-to-end Drug Development, United States
Headquarters:
Guilford, Connecticut, United States
Founded Date:
2013-01-01
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
2
Total Funding:
98000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017-03-30
Last Funding Type:
Series C
Register and Claim Ownership